Avidity Partners Management LP Arcutis Biotherapeutics, Inc. Transaction History

Avidity Partners Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$10.23 - $17.14 $1.29 Million - $2.17 Million	-126,500 Reduced 7.21%	1,628,500 $17.9 Million
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $13.4 Million - $19.6 Million	960,500 Added 120.89%	1,755,000 $26 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $14.2 Million - $21.4 Million	794,500 New	794,500 $15.2 Million

196

130M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $797M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.